Anal & Colorectal Cancer Date held: March 21st, 2019 Presented by: Helene Hutchings, Anal Cancer – A Bum Rap Webinar Information: For Colorectal Cancer Awareness Month, CCSN welcomed back Helene Hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the symptoms & risk factors of these cancers, as well as treatment options that are available. She also discussed prevention of anal
Archives: News
Colorectal cancer researcher needs more B.C. survivors
Dr. Mary De Vera has a research grant to study one of the most common types of cancer in Canada, and personal experience of its effects to motivate her search for answers. Now all she needs is the experience of a few more colorectal cancer survivors, via an online survey. Learn more here.
Watch our most recent webinar! CDIAC to CADTH: How the pan-Canadian Oncology Drug Review (pCODR) is changing to accommodate provincial cancer agency needs
CDIAC to CADTH: How the pan-Canadian Oncology Drug Review (pCODR) is changing to accommodate provincial cancer agency needs Date held: March 14th, 2019 Presented by: Gerry Jeffcott, 3Sicty Public Affairs with guest panelists Louise Binder & Martine Elias Webinar Information: This webinar was hosted by Gerry Jeffcott from 3Sixty Public Affairs. He summarized some important changes that the Canadian Agency for Drugs and Technologies in
Watch our most recent webinar! Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue)
Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) Date held: March 7th, 2019 Presented by: Dr. Kelvin Chan Webinar Information: Dr. Kelvin Chan gave a short explanation on what real-world evidence (RWE) is, how they can be used in cancer care and what benefits patients can get from the real-world evidence. He will also introduce the Canadian Real-world Evidence for Value of Cancer Drugs
CCSN Voices Support of Pharmacare Council Interim Report
[OTTAWA, ON March 7th, 2019] – The Canadian Cancer Survivor Network (CCSN), a national charitable organization of cancer patients, survivors, caregivers and community partners, welcomes the Advisory Council on the Implementation of National Pharmacare’s Interim Report. CCSN is pleased to hear the Council’s acknowledgement that the current healthcare system does not provide patients and consumers timely, equitable, affordable and accessible means to medically necessary therapies.
CCSN & Lung Cancer Canada to MPPs: Lung Cancer Patients have a Right2Survive
Lung cancer is the most commonly diagnosed cancer in Canada. It kills over 20,000 Canadians every year – more people than colorectal, breast, and prostate cancers combined. Despite being the number one killer, outcomes in lung cancer fall behind other cancers. All cancer patients deserve a chance to become cancer survivors, and this includes lung cancer patients too. The Canadian Cancer Survivor Network (CCSN), in